Reuters logo
BRIEF-Masimo Corp says appears co addressed violations contained in FDA warning letter regarding Irvine facility
June 6, 2017 / 10:37 AM / 5 months ago

BRIEF-Masimo Corp says appears co addressed violations contained in FDA warning letter regarding Irvine facility

June 6 (Reuters) - Masimo Corp

* Masimo - ‍on May 26, received letter from FDA indicating FDA has completed an evaluation of Masimo’s corrective actions in response to warning letter​

* Masimo Corp - ‍ based on FDA’s evaluation, appears co addressed violations contained in warning letter regarding compliance practices at Irvine, California facility​

* Masimo Corp - ‍letter indicated that future FDA inspections and regulatory activities will further assess adequacy and sustainability of corrections​ Source text for Eikon: (bit.ly/2rwbfoJ) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below